[
    {
        "query": "\n                Analyze the provided CSV file and generate a detailed description of each row by extracting and summarizing its features in a continuous sentence. For each row:\n\n                1. Identify and list the column names and their corresponding values.\n                2. Present the features in the row in a seamless sentence structure, describing the relationship or context between them.\n                3. Provide a summary statement based on the data, capturing notable insights, patterns, or potential interpretations.\n                ",
        "response": "Row 182 shows that the drug Alemtuzumab (also known as Campath and LEMTRADA), with RXCUI 117055, is indicated for Multiple sclerosis (relapsing-remitting), Chronic lymphocytic leukaemia, T-cell prolymphocytic leukaemia, and Mycosis fungoides, corresponding to MONDO IDs MONDO:0005301, MONDO:0005314, MONDO:0004948, MONDO:0019468, and MONDO:0009691, and UMLS CUI IDs C0026769, C0751967, C0023434, C2363142, and C0026948.  This indicates Alemtuzumab's use in treating both autoimmune and hematological cancers.\n\nRow 181 indicates that the drug Aciphex (Rabeprazole and Rabeprazole Sodium), with RXCUI 114979, treats Gastroesophageal reflux disease (GERD),  represented by MONDO:0007186 and UMLS C0017168.  This shows Aciphex is used specifically for the treatment of GERD.\n\n\nRow 183 shows that Azopt (Brinzolamide), with RXCUI 194881, is indicated for Glaucoma (including open-angle glaucoma) and Ocular hypertension,  corresponding to MONDO IDs MONDO:0005041, MONDO:0006875, and MONDO:0005338, and UMLS CUI IDs C0017601, C0028840, and C0017612. This highlights Azopt's role in managing eye pressure related conditions.\n\n\nRow 180 shows that Benzoyl Peroxide (also known as Proactiv and Proactiv Repairing Treatment), with RXCUI 1418, is indicated for treating Acne, represented by MONDO:0011438 and UMLS C0702166. This confirms Benzoyl Peroxide's common use as an acne treatment.\n\n\nRow 184 shows that Gleostine (Lomustine), with RXCUI 6466, is indicated for malignant brain neoplasms,  represented by MONDO:0001657 and UMLS C0153633.  This highlights Lomustine's use in oncology, specifically for brain cancers."
    }
]